U.S. World Business Lifestyle
Today: April 23, 2026
Today: April 23, 2026

FDA approval

Business|Health|Lifestyle|Science|Technology

US FDA rejects AbbVie's wrinkle treatment due to manufacturing concerns

AbbVie said on Thursday the U.S.

US FDA rejects AbbVie's wrinkle treatment due to manufacturing concerns
Business|Health|Science

FDA declines Grace's stroke drug over manufacturing and packaging issues, shares slump

Grace Therapeutics said on Thursday the U.S.

FDA declines Grace's stroke drug over manufacturing and packaging issues, shares slump
Business|Economy|Finance|Health|Science|Technology

US health regulators to speed up Medicare device coverage

U.S. health regulators announced a new program to speed up Medicare coverage for certain medical devices on Thursday

US health regulators to speed up Medicare device coverage
Health|Political|Science|World

Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic

Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic

Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic
Entertainment|Health|Political|Science|World

Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine

Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
Business|Economy|Health|Science

Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk

The U.S.

Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk
Health|Science|World

Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the

Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles
Business|Economy|Health|Lifestyle|Science|Technology

Novo Nordisk launches higher-dose Wegovy in the United States

Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United States.

Novo Nordisk launches higher-dose Wegovy in the United States
Education|Health|Political|Science

'It's saving his life': FDA approves new drug for rare disease, helping Kansas family

'It's saving his life': FDA approves new drug for rare disease, helping Kansas family

'It's saving his life': FDA approves new drug for rare disease, helping Kansas family
Business|Health|Lifestyle|Science|Technology

Company develops robot to take guesswork out of dental surgery

Company develops robot to take guesswork out of dental surgery

Company develops robot to take guesswork out of dental surgery
Business|Economy|Entertainment|Environment|Health|Lifestyle|Political|Science|Technology|Travel

Artemis launch, flipping voters, fed-up drivers: Catch up on the day’s stories

Artemis launch, flipping voters, fed-up drivers: Catch up on the day’s stories

Artemis launch, flipping voters, fed-up drivers: Catch up on the day’s stories
Business|Economy|Health|Science|Technology

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

U.S. health officials have approved a new weight-loss pill from Eli Lilly

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity
Business|Health|Lifestyle|Science|Technology

Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used

Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used

Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used
Business|Economy|Health|Science

FDA finds little evidence that a drug touted by Trump can help people with autism

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism

FDA finds little evidence that a drug touted by Trump can help people with autism
Business|Health|Science|US

FDA approves leucovorin for rare genetic condition, but not for autism

FDA approves leucovorin for rare genetic condition, but not for autism

FDA approves leucovorin for rare genetic condition, but not for autism
Health|Interview|Lifestyle|Science

Kansas City priest thankful for new heart drug that 'changed his life'

Kansas City priest thankful for new heart drug that 'changed his life'

Kansas City priest thankful for new heart drug that 'changed his life'
Business|Health|Science|Technology|World

Moderna says the FDA will consider its new flu shot after resolving a public dispute

Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults after all

Moderna says the FDA will consider its new flu shot after resolving a public dispute
Business|Food|Health|Lifestyle|Science

FDA approves natural food dye beetroot red, expands the use of spirulina

FDA approves natural food dye beetroot red, expands the use of spirulina

FDA approves natural food dye beetroot red, expands the use of spirulina
Business|Economy|Health|Science

US regulators approve Wegovy pill for weight loss

U.S. regulators have approved a pill version of the weight-loss drug Wegovy

US regulators approve Wegovy pill for weight loss
Health|Science|Technology|World

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance
Health|Science

New FDA-approved glasses can slow nearsightedness in kids

A new type of lens approved by the FDA promises to slow nearsightedness in children

New FDA-approved glasses can slow nearsightedness in kids
Health|Political|Science|World

Republican-led states challenge FDA approval of new generic abortion pill

Three Republican-led states have moved to broaden their lawsuit seeking to restrict access to the abortion pill mifepristone, aiming to block the U.S.

Republican-led states challenge FDA approval of new generic abortion pill
Business|Health|Science|Technology|US|World

US FDA approves Kura-Kyowa's blood cancer therapy

The U.S.

US FDA approves Kura-Kyowa's blood cancer therapy
Business|Health|Science|Technology

US FDA unveils new pathway to approve personalized therapies

The U.S.

US FDA unveils new pathway to approve personalized therapies